Peter David Rands

Peter David Rands is a declared insider of Small Pharma Inc. (formerly, Unilock Capital Corp.), with filings sourced from SEDI. Between 7 March 2022 and 25 August 2023, the trades on record add up to 57 filings.

In open-market terms, that means 39 purchases worth €127k on one side and 17 sales worth €195k on the other. Taken together, the sales exceed the purchases by €68k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: no purchases and 13 sales on the market.

A typical purchase (the median) is worth €2,341.

The newest entry dates from 28 August 2023: an open-market sale of €30k, in Small Pharma Inc. (formerly, Unilock Capital Corp.). The last purchase on record was published on 3 September 2022, which is 1,512 days ago. Filings reach the SEDI feed a median of 3 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.